• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用氟脱氧葡萄糖正电子发射断层扫描联合前哨淋巴结活检评估乳腺癌腋窝受累情况

Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.

作者信息

Gil-Rendo A, Zornoza G, García-Velloso M J, Regueira F M, Beorlegui C, Cervera M

机构信息

Department of General Surgery, Clinica Universitaria of Navarra, C/Pío XII 36, 31008 Pamplona, Navarre, Spain.

出版信息

Br J Surg. 2006 Jun;93(6):707-12. doi: 10.1002/bjs.5338.

DOI:10.1002/bjs.5338
PMID:16622900
Abstract

BACKGROUND

This study analysed the value of [(18)F]fluorodeoxyglucose positron emission tomography (FDG-PET) in detecting axillary lymph node involvement in women with breast cancer.

METHODS

In the first 150 women in this prospective study, axillary lymph node dissection (ALND) was performed regardless of the PET results. In a second group (125 women) FDG-PET was complemented with sentinel lymph node biopsy (SLNB) only in those who did not have pathological axillary uptake.

RESULTS

The sensitivity and specificity of FDG-PET in detecting axillary involvement was 84.5 and 98.5 per cent respectively in the whole series of 275 patients, with two false-positive and 22 false-negative results. False-negative results were associated with some intrinsic tumour characteristics. In 21 women, PET revealed pathological uptake, suggesting involvement of the internal mammary lymph node chain. Whole-body PET identified a second synchronous tumour in five asymptomatic patients and haematogenous metastases in two patients.

CONCLUSION

The high positive predictive value of PET (98.4 per cent) suggests that FDG uptake in the axilla could be an indication for full ALND without previous SLNB.

摘要

背景

本研究分析了[18F]氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)在检测乳腺癌女性腋窝淋巴结受累情况中的价值。

方法

在这项前瞻性研究的前150名女性中,无论PET结果如何,均进行腋窝淋巴结清扫术(ALND)。在第二组(125名女性)中,仅对那些腋窝无病理性摄取的患者,FDG-PET联合前哨淋巴结活检(SLNB)。

结果

在整个275例患者系列中,FDG-PET检测腋窝受累的敏感性和特异性分别为84.5%和98.5%,有2例假阳性和22例假阴性结果。假阴性结果与一些肿瘤固有特征相关。在21名女性中,PET显示病理性摄取,提示内乳淋巴结链受累。全身PET在5名无症状患者中发现了第二个同步肿瘤,在2名患者中发现了血行转移。

结论

PET的高阳性预测值(98.4%)表明,腋窝FDG摄取可能是无需先行SLNB而直接进行完整ALND的指征。

相似文献

1
Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer.采用氟脱氧葡萄糖正电子发射断层扫描联合前哨淋巴结活检评估乳腺癌腋窝受累情况
Br J Surg. 2006 Jun;93(6):707-12. doi: 10.1002/bjs.5338.
2
Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.FDG-PET对乳腺癌患者转移性前哨淋巴结及非前哨淋巴结转移时囊外侵犯的预测
Anticancer Res. 2016 Apr;36(4):1785-9.
3
Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study.前瞻性研究 2-[¹⁸F]氟脱氧葡萄糖正电子发射断层扫描在乳腺癌患者区域淋巴结疾病播散评估中的作用:安大略临床肿瘤学组研究。
J Clin Oncol. 2012 Apr 20;30(12):1274-9. doi: 10.1200/JCO.2011.38.1103. Epub 2012 Mar 5.
4
FDG-PET for axillary lymph node staging in primary breast cancer.用于原发性乳腺癌腋窝淋巴结分期的氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)
Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. doi: 10.1007/s00259-004-1531-z. Epub 2004 May 5.
5
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases.18F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)与前哨淋巴结活检在识别隐匿性腋窝转移方面价值的比较研究
Ann Oncol. 2007 Mar;18(3):473-8. doi: 10.1093/annonc/mdl425. Epub 2006 Dec 12.
6
A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.对早期乳腺癌患者进行正电子发射断层扫描、前哨淋巴结活检及标准腋窝淋巴结清扫术以进行腋窝分期的前瞻性评估。
Ann Surg Oncol. 2004 Sep;11(9):846-53. doi: 10.1245/ASO.2004.11.033. Epub 2004 Aug 16.
7
18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer.18F-FDG正电子发射断层显像(PET)联合前哨淋巴结活检用于检测乳腺癌腋窝受累情况。
Eur J Surg Oncol. 2004 Feb;30(1):15-9. doi: 10.1016/j.ejso.2003.10.010.
8
Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.使用术前18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描融合成像确定临床腋窝淋巴结阴性乳腺癌前哨淋巴结活检的指征
Jpn J Clin Oncol. 2009 Jan;39(1):16-21. doi: 10.1093/jjco/hyn120. Epub 2008 Nov 8.
9
Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.新辅助化疗后乳腺癌患者的淋巴闪烁显像。前哨淋巴结阴性患者的诊断价值及检查
Nuklearmedizin. 2011;50(1):33-8. doi: 10.3413/nukmed-0320-10-05.
10
The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.超声检查和氟代脱氧葡萄糖正电子发射断层扫描在乳腺癌腋窝淋巴结分期中的作用。
Acta Radiol. 2010 Oct;51(8):859-65. doi: 10.3109/02841851.2010.501342.

引用本文的文献

1
Therapeutic impact of F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG PET/CT)对临床 I 期和 IIA 期、HER2 阳性或三阴性乳腺癌患者初始分期的治疗影响。
Breast Cancer Res Treat. 2024 Oct;207(3):551-559. doi: 10.1007/s10549-024-07386-8. Epub 2024 Jun 5.
2
Role of F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of breast carcinoma: Indications and pitfalls with illustrative case examples.F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在乳腺癌评估中的作用:指征及陷阱并附病例说明
World J Nucl Med. 2020 Jul 1;19(3):187-196. doi: 10.4103/wjnm.WJNM_88_19. eCollection 2020 Jul-Sep.
3
PET/MRI in Oncological Imaging: State of the Art.正电子发射断层扫描/磁共振成像在肿瘤影像学中的应用:现状。
Diagnostics (Basel). 2015 Jul 21;5(3):333-57. doi: 10.3390/diagnostics5030333.
4
Positron Emission Tomography in Breast Cancer.正电子发射断层扫描在乳腺癌中的应用。
Diagnostics (Basel). 2015 Mar 16;5(1):61-83. doi: 10.3390/diagnostics5010061.
5
Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.(18)F-FDG PET/CT 对乳腺癌患者腋窝淋巴结分期的诊断和预后价值。
Jpn J Radiol. 2016 Mar;34(3):220-8. doi: 10.1007/s11604-015-0515-1. Epub 2015 Dec 29.
6
Prospective evaluation of the feasibility of sentinel lymph node biopsy in breast cancer patients with negative axillary conversion after neoadjuvant chemotherapy.新辅助化疗后腋窝淋巴结无转移的乳腺癌患者前哨淋巴结活检可行性的前瞻性评估
Cancer Res Treat. 2015 Jan;47(1):26-33. doi: 10.4143/crt.2013.208. Epub 2014 Aug 29.
7
Tumour 18 F-FDG Uptake on preoperative PET/CT may predict axillary lymph node metastasis in ER-positive/HER2-negative and HER2-positive breast cancer subtypes.术前PET/CT检查时肿瘤的18F-FDG摄取情况可能预测雌激素受体阳性/人表皮生长因子受体2阴性及人表皮生长因子受体2阳性乳腺癌亚型的腋窝淋巴结转移。
Eur Radiol. 2015 Apr;25(4):1172-81. doi: 10.1007/s00330-014-3452-y. Epub 2014 Oct 9.
8
(18)F-FDG PET/CT with Contrast Enhancement for Evaluation of Axillary Lymph Node Involvement in T1 Breast Cancer.(18) 采用对比增强的F-FDG PET/CT评估T1期乳腺癌腋窝淋巴结受累情况
Nucl Med Mol Imaging. 2010 Sep;44(3):170-6. doi: 10.1007/s13139-010-0035-y. Epub 2010 Jun 15.
9
The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and (18)F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast Cancer.超声、增强 MRI 和 (18)F-FDG PET/CT 对 T1 期乳腺癌腋窝淋巴结转移的对比研究。
J Breast Cancer. 2013 Sep;16(3):315-21. doi: 10.4048/jbc.2013.16.3.315. Epub 2013 Sep 30.
10
Advances in molecular imaging for breast cancer detection and characterization.用于乳腺癌检测和特征描述的分子成像技术进展。
Breast Cancer Res. 2012 Mar 16;14(2):206. doi: 10.1186/bcr3094.